SOAR: Pathway to Wellness

The SOAR: Pathway to Wellness Program (2017-2019) is a community-driven program aimed at improving the health and health equity of Indigenous peoples living with diabetes. Indigenous communities and their local healthcare organizations have formed a partnership with Western University’s Diabetes Research Team to adapt and strengthen the effectiveness and scalability of a diabetes quality improvement (QI) program. This QI Program includes QI training, coaching and tools to support community-designed initiativesto improve the quality of diabetes care and well-being of community members.

Four core objectives of SOAR:

Engage

  • Engage community partners and key stakeholders to support meaningful participation and leadership

Review

  • Review, improve and adapt the diabetes quality improvement strategy with community partners

Evaluate

    • Evaluate the effectiveness of the adapted diabetes quality improvement strategy

Develop

  • Develop community-driven plans for sustainability and scale-up for the adapted diabetes quality improvement strategy

Program Materials

SOAR Program Overview:

Watch the overview of the SOAR Program and learn more about its core objectives and guiding principles. 


First Nations Diabetes Surveillance System (FNDSS) Overview

Providing a secure, centralized and easily accessible web-based system to track and monitor trends in diabetes rates over time in First Nations communities. 

 Member Area

Updates & Announcements

Workshop-2-thumbnail_415x194.png

SOAR: Pathway to Wellness | Workshop #3 Dates to be announced

The SOAR Program third Indigenous Quality Improvement Workshop over videoconference which was meant to be held February 27 & 28, 2019, unfortunately had to be cancelled due to unforseen events. We are working hard to finalize dates with our four Indigenous community partners. If you have any questions regarding the workshop please contact Chris Ryan.

 

Our Funding Partners

This program has been generously supported by The Canadian Institutes of Health Research (CIHR), the Juvenile Diabetes Research Foundation (JDRF) and AstraZeneca Canada Inc.

CIHR.png
JDRF.png
astra-zeneca.png